We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins

Product News   Sep 04, 2020

 
Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Novasina Announces Instruments Compliant With New USP Water Activity Method

Product News

The United States Pharmacopeia will release the new method USP <922> in May 2021, which will outline recommendations for the determination of water activity.

READ MORE

Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding

Product News

Mologic has announced that its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics initiative launched by the U.S. National Institutes of Health. The initiative aims to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.

READ MORE

Avacta Announces Distribution Agreement With ABCAM plc

Product News

Avacta Group plc has announced that it has entered into a global distribution agreement with ABCAM plc to sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer® reagents.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE